Vaccines & Pipeline Strategy
Moderna cuts forecast amid declining COVID vaccine demand
By Intent.Health Team • May 1, 2026
What’s happening
Moderna lowered its revenue forecast due to falling demand for COVID-19 vaccines, as pandemic-driven sales continue to decline.
What’s changing / Business impact
-
COVID vaccine market shrinking rapidly.
-
Companies shifting focus to: next-gen vaccines and mRNA pipeline expansion.
-
Revenue volatility increases as pandemic tailwinds fade.
Why this matters
Pandemic-era demand is transitioning into a post-COVID baseline.
This shows:
-
Pharma companies must replace temporary revenue spikes.
-
Long-term value depends on pipeline diversification.
-
Demand in vaccines is now cyclical, not guaranteed.